Colorectal Cancer Evidence-Based Chemotherapy Strategies /
Management options for patients with colorectal cancer have undergone d- matic changes over the past decade. Whereas at the start of 1996 only one drug, 5-Fluorouracil, was available for the treatment of this disease, a mere 10 yr later, six drugs are licensed for use in colorectal cancer, and other...
| Συγγραφή απο Οργανισμό/Αρχή: | |
|---|---|
| Άλλοι συγγραφείς: | , |
| Μορφή: | Ηλεκτρονική πηγή Ηλ. βιβλίο |
| Γλώσσα: | English |
| Έκδοση: |
Totowa, NJ :
Humana Press,
2007.
|
| Σειρά: | Current Clinical Oncology
|
| Θέματα: | |
| Διαθέσιμο Online: | Full Text via HEAL-Link |
Πίνακας περιεχομένων:
- Molecular Biology of Colon Cancer
- Chemoprevention of Colorectal Cancer
- Colorectal Cancer Screening and Surveillance
- Cytotoxic Chemotherapy for Metastatic Colorectal Cancer
- Integration of Antiangiogenic Strategies Into Colorectal Cancer Treatment
- The Role of EGFR Inhibition in Colorectal Cancer
- Second-Line Strategies in the Treatment of Patients With Metastatic Colorectal Cancer
- Adjuvant Chemotherapy for Colon Cancer
- Management of Locally Advanced Rectal Cancer
- Rationale for Adjuvant and Neoadjuvant Chemotherapy in the Resection of Liver Metastases
- Percutaneous Radiofrequency Ablation in the Management of Patients With Colorectal Cancer
- Colorectal Cancer Imaging
- Nursing Issues in Colorectal Cancer Chemotherapy
- Pain Management in the Colorectal Cancer Patient
- Novel Agents and New Paradigms for Colorectal Cancer Beyond EGFR and VEGF.
